{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T16:29:12Z","timestamp":1794155352584,"version":"4.8.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32330058"],"award-info":[{"award-number":["32330058"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82361168639"],"award-info":[{"award-number":["82361168639"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82125035"],"award-info":[{"award-number":["82125035"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404525"],"award-info":[{"award-number":["82404525"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["GZC20240305"],"award-info":[{"award-number":["GZC20240305"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012165","name":"Key Technologies Research and Development Program","doi-asserted-by":"publisher","award":["2024YFE0216000"],"award-info":[{"award-number":["2024YFE0216000"]}],"id":[{"id":"10.13039\/501100012165","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2021-01-07-00-07-E00081"],"award-info":[{"award-number":["2021-01-07-00-07-E00081"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpha.2026.101609","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:01:25Z","timestamp":1773759685000},"page":"101609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Standardizing pre-existing anti-PEG antibody detection: A key to clarifying their binding features and clinical relevance"],"prefix":"10.1016","volume":"16","author":[{"given":"Jiaru","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-2829","authenticated-orcid":false,"given":"Changyou","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2026.101609_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrd1033","article-title":"Effect of pegylation on pharmaceuticals","volume":"2","author":"Harris","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jpha.2026.101609_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil\u00ae: the first FDA-approved nano-drug: lessons learned","volume":"160","author":"Barenholz","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2026.101609_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpha.2026.101609_bib4","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1517\/17425255.2014.967679","article-title":"Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns","volume":"10","author":"Zhang","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jpha.2026.101609_bib5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1021\/acsbiomedchemau.4c00042","article-title":"Antigenicity extension: a novel concept explained by the immunogenicity of PEG","volume":"5","author":"Shiraishi","year":"2025","journal-title":"ACS Bio Med Chem Au"},{"key":"10.1016\/j.jpha.2026.101609_bib6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated lipid nanoparticle formulations: immunological safety and efficiency perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jpha.2026.101609_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpha.2026.101609_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jconrel.2016.06.040","article-title":"Anti-PEG antibodies in the clinic: current issues and beyond PEGylation","volume":"244","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2026.101609_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jconrel.2023.01.012","article-title":"Investigation of anti-PEG antibody response to PEG-containing cosmetic products in mice","volume":"354","author":"Ibrahim","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2026.101609_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jconrel.2023.09.003","article-title":"Accelerated blood clearance of PEGylated nanoparticles induced by PEG-based pharmaceutical excipients","volume":"363","author":"Miao","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2026.101609_bib11","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpha.2026.101609_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3324\/haematol.2020.258525","article-title":"Pre-existing antibodies against polyethylene glycol reduce asparaginase activities on first administration of pegylated E. coli asparaginase in children with acute lymphocytic leukemia","volume":"107","author":"Khalil","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.jpha.2026.101609_bib13","doi-asserted-by":"crossref","first-page":"11769","DOI":"10.1021\/acsnano.2c04543","article-title":"Anti-PEG antibodies boosted in humans by SARS-CoV-2 lipid nanoparticle mRNA vaccine","volume":"16","author":"Ju","year":"2022","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpha.2026.101609_bib14","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.3390\/ijms23168838","article-title":"Monitoring anti-PEG antibodies level upon repeated lipid nanoparticle-based COVID-19 vaccine administration","volume":"23","author":"Guerrini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpha.2026.101609_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/jnt5030007","article-title":"Anti-poly(ethylene glycol) (PEG) antibodies: from where are we coming and where are we going","volume":"5","author":"Simberg","year":"2024","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.jpha.2026.101609_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/cpdd.1225","article-title":"Clinical impact of antipolyethylene glycol (PEG) antibody in hematological patients administered PEGylated-granulocyte colony-stimulating factor, Clin","volume":"12","author":"Okada","year":"2023","journal-title":"Pharmacol. Drug Dev."},{"key":"10.1016\/j.jpha.2026.101609_bib17","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0168-8278(10)60309-1","article-title":"307 high prevalence of pre-existing antibodies against polyethylene glycol (peg) in hepatitis C (hcv) patients which is not associated with impaired response to peg-interferon","volume":"52","author":"Tillmann","year":"2010","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jpha.2026.101609_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s40883-021-00198-y","article-title":"Clinical relevance of pre-existing and treatment-induced anti-poly(ethylene glycol) antibodies","volume":"8","author":"Freire Haddad","year":"2022","journal-title":"Regen. Eng. Transl. Med."},{"key":"10.1016\/j.jpha.2026.101609_bib19","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41565-022-01071-x","article-title":"Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines","volume":"17","author":"Szebeni","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jpha.2026.101609_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/ni.2194","article-title":"B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen","volume":"13","author":"Puga","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpha.2026.101609_bib21","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni.1914","article-title":"The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88","volume":"11","author":"He","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpha.2026.101609_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies: current situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jpha.2026.101609_bib23","doi-asserted-by":"crossref","first-page":"10661","DOI":"10.1021\/acs.analchem.6b03109","article-title":"Measurement of pre-existing IgG and IgM antibodies against polyethylene glycol in healthy individuals","volume":"88","author":"Chen","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpha.2026.101609_bib24","doi-asserted-by":"crossref","first-page":"11804","DOI":"10.1021\/acs.analchem.6b03437","article-title":"Analysis of pre-existing IgG and IgM antibodies against polyethylene glycol (PEG) in the general population","volume":"88","author":"Yang","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpha.2026.101609_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.toxrep.2020.12.022","article-title":"Flow cytometry analysis of anti-polyethylene glycol antibodies in human plasma","volume":"8","author":"Fang","year":"2021","journal-title":"Toxicol. Rep."},{"key":"10.1016\/j.jpha.2026.101609_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2019.112669","article-title":"A generic method for the detection of polyethylene glycol specific IgG and IgM antibodies in human serum","volume":"474","author":"Ehlinger","year":"2019","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.jpha.2026.101609_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123695","article-title":"Effects of PEG antibodies on in vivo performance of LNP-mRNA vaccines","volume":"650","author":"Yang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2026.101609_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106678","article-title":"Antibodies against polyethylene glycol in human blood: a literature review","volume":"102","author":"Hong","year":"2020","journal-title":"J. Pharmacol. Toxicol. Meth."},{"key":"10.1016\/j.jpha.2026.101609_bib29","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1021\/acs.analchem.7b02447","article-title":"Sensitive and quantitative detection of anti-poly(ethylene glycol) (PEG) antibodies by methoxy-PEG-coated surface plasmon resonance sensors","volume":"89","author":"Zhang","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpha.2026.101609_bib30","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1208\/s12248-015-9799-4","article-title":"Development of a generic anti-PEG antibody assay using BioScale's acoustic membrane MicroParticle technology","volume":"17","author":"Dong","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.jpha.2026.101609_bib31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1039\/D3TB01723K","article-title":"Distinguishing anti-PEG antibodies by specificity for the PEG terminus using nanoarchitectonics-based antibiofouling cello-oligosaccharide platforms","volume":"12","author":"Sugiura","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jpha.2026.101609_bib32","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1021\/acs.molpharmaceut.4c00278","article-title":"Optimized enzyme-linked immunosorbent assay for anti-PEG antibody detection in healthy donors and patients treated with PEGylated liposomal doxorubicin","volume":"21","author":"Li","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpha.2026.101609_bib33","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jconrel.2024.01.003","article-title":"Development of anti-PEG IgG\/IgM\/IgE ELISA assays for profiling anti-PEG immunoglobulin response in PEG-sensitized individuals and patients with alpha-gal allergy","volume":"366","author":"Li","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2026.101609_bib34","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1021\/bc100067t","article-title":"Sensitive quantification of PEGylated compounds by second-generation anti-poly(ethylene glycol) monoclonal antibodies","volume":"21","author":"Su","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jpha.2026.101609_bib35","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1021\/bc200551b","article-title":"Role of the methoxy group in immune responses to mPEG-protein conjugates","volume":"23","author":"Sherman","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jpha.2026.101609_bib36","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jpha.2026.101609_bib37","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s11095-016-1961-x","article-title":"The mystery of antibodies against polyethylene glycol (PEG) - what do we know?","volume":"33","author":"Lubich","year":"2016","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpha.2026.101609_bib38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2014.09.047","article-title":"Influence of dose and animal species on accelerated blood clearance of PEGylated liposomal doxorubicin","volume":"476","author":"Suzuki","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jpha.2026.101609_bib39","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1248\/bpb.b13-00562","article-title":"Ex-vivo\/in-vitro anti-polyethylene glycol (PEG) immunoglobulin M production from murine splenic B cells stimulated by PEGylated liposome","volume":"36","author":"Abu Lila","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.jpha.2026.101609_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/antib9040053","article-title":"Structure, function, and therapeutic use of IgM antibodies","volume":"9","author":"Keyt","year":"2020","journal-title":"Antibodies"},{"key":"10.1016\/j.jpha.2026.101609_bib41","doi-asserted-by":"crossref","first-page":"19265","DOI":"10.1039\/C9NR05790K","article-title":"Isothermal titration calorimetry as a complementary method for investigating nanoparticle-protein interactions","volume":"11","author":"Prozeller","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.jpha.2026.101609_bib42","doi-asserted-by":"crossref","first-page":"7808","DOI":"10.1021\/acsnano.9b07218","article-title":"Premature drug release from polyethylene glycol (PEG)-coated liposomal doxorubicin via formation of the membrane attack complex","volume":"14","author":"Chen","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jpha.2026.101609_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2013.07.026","article-title":"The accelerated blood clearance (ABC) phenomenon: clinical challenge and approaches to manage","volume":"172","author":"Abu Lila","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jpha.2026.101609_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijbiomac.2016.03.030","article-title":"Comprehensive study on the structure of the BSA from extended-to aged form in wide (2-12) pH range","volume":"88","author":"Varga","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jpha.2026.101609_bib45","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejpb.2018.02.019","article-title":"A hydroxyl PEG version of PEGylated liposomes and its impact on anti-PEG IgM induction and on the accelerated clearance of PEGylated liposomes","volume":"127","author":"Shimizu","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jpha.2026.101609_bib46","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1038\/s44222-025-00321-6","article-title":"Polyethylene glycol immunogenicity in nanomedicine","volume":"3","author":"Chen","year":"2025","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.jpha.2026.101609_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0301-4622(75)80030-5","article-title":"Theory of hapten binding to IgM: the question of repulsive interactions between binding sites","volume":"3","author":"Goldstein","year":"1975","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.jpha.2026.101609_bib48","doi-asserted-by":"crossref","first-page":"11900","DOI":"10.1073\/pnas.1901841116","article-title":"Insights into IgM-mediated complement activation based on in situ structures of IgM-C1-C4b","volume":"116","author":"Sharp","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jpha.2026.101609_bib49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/80886","article-title":"Fc\u03b1\/\u03bc receptor mediates endocytosis of IgM-coated microbes","volume":"1","author":"Shibuya","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jpha.2026.101609_bib50","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41577-022-00825-x","article-title":"Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines","volume":"23","author":"Ju","year":"2023","journal-title":"Nat. Rev. Immunol."}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209517792600064X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209517792600064X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:00:13Z","timestamp":1792598413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209517792600064X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S209517792600064X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2026.101609","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardizing pre-existing anti-PEG antibody detection: A key to clarifying their binding features and clinical relevance","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2026.101609","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101609"}}